EUVIMEDEUVIMED entdecken
Crossref

Resilience of tigecycline heteroresistance phenotype in Acinetobacter baumannii

Jeongwoo Jo, Sun Ju Kim iD, Ki Tae Kwon, Kwan Soo Ko iD

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkae436 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Jeongwoo Jo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, School of Medicine, Sungkyunkwan University, Suwon, Republic of Korea. Hauptthemen laut MEDLINE: Tigecycline, Acinetobacter baumannii, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Basic Science Research Program of the National Research Program of the National Research Foundation, Korean government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heteroresistance, frequently observed in diverse bacterial species, imposes clinical challenges. For this study, we investigated the stability and resilience of tigecycline heteroresistance in Acinetobacter baumannii.

Methods

Four tigecycline-heteroresistant (HR) A. baumannii strains and resistant populations (RPs) obtained from them were subjected to laboratory evolution assays for 30 days in antibiotic-free media. The heteroresistance phenotype was determined using a population analysis. Bacterial growth curves and in vitro competitiveness were determined to investigate the fitness cost of heteroresistance. Tigecycline efficacy was evaluated using an in vitro time–killing assay. Genetic mutations were identified using whole genome sequencing, and expression of genes in the two-component systems was also evaluated.

Results

Tigecycline heteroresistance was preserved even in antibiotic-free media, and tigecycline-RPs reverted to heteroresistance during serial culture without tigecycline pressure. The tigecycline-RPs showed a higher fitness cost than their respective HR strains, and the HR strains exhibited a survival advantage upon tigecycline treatment. Although the AdeABC efflux pump was overexpressed in the tigecycline-RPs, it was down-regulated in the HR strains.

Conclusions

Our data indicate that tigecycline heteroresistance is a highly resilient phenotype in A. baumannii that gives a high fitness advantage to bacteria in terms of competitiveness and response to antibiotic pressure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TigecyclineAcinetobacter baumanniiAnti-Bacterial AgentsDrug Resistance, BacterialMicrobial Sensitivity TestsPhenotypeWhole Genome SequencingMutationBacterial ProteinsHumansAcinetobacter Infections

Substanzen

TigecyclineAnti-Bacterial AgentsBacterial Proteins

Autor:innen und Institutionen

  • Department of Microbiology, School of Medicine, Sungkyunkwan University, Suwon, Republic of Korea.
  • Department of Pharmacy, School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
  • Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.

ORCID-Profile: Sun Ju Kim, Kwan Soo Ko

Förderung

  • Basic Science Research Program of the National Research Program of the National Research Foundation
  • Korean government

Zitieren

APA

Jo, J., Kim, S. J., Kwon, K. T., & Ko, K. S. (2025). Resilience of tigecycline heteroresistance phenotype in Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae436

Vancouver

Jo J, Kim SJ, Kwon KT, Ko KS. Resilience of tigecycline heteroresistance phenotype in Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkae436

BibTeX
@article{Jo2025,
  author = {Jo, Jeongwoo and Kim, Sun Ju and Kwon, Ki Tae and Ko, Kwan Soo},
  title = {Resilience of tigecycline heteroresistance phenotype in Acinetobacter baumannii},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkae436}
}
Kostenlos starten →